Certain initial public offers may only be for institutional investors
Fresh funds will reduce pressure on balance sheet but a lot will depend on the company's ability to return to growth
The IPO, which concluded on May 3, was subscribed 4.8 times. The IPO was priced between Rs 99 and Rs 100 per unit. The InvIT had raised Rs 7,735 crore
The company has filed DRHP to raise Rs 3,600 crore
India's largest airline by market share will use the proceeds to meet debt obligations, pay oil companies.
At 670, the number of issues / IPOs in the first five months of CY21 is the second-highest since the calendar year 2000 when 677 IPOs hit the Street globally.
Regulator mulls replacing concept of 'promoter' with 'person in control'
A massive 133% jump in the proceeds from initial public offerings (IPOs) has seen the deal street on a near roll in spite of the raging second wave of the pandemic
Institutional and non-institutional portions were subscribed 4.6x and 5.1x
Chemplast Sanmar Ltd has filed preliminary papers with capital markets regulator Sebi to raise Rs 3,500 crore through an initial share sale
The price band for the IPO is 99-100 per unit of Rs 100 each
The IPO offer includes a fresh issue by the company worth Rs 7,500 crore, and and an offer for sale by the selling shareholder Info Edge
PowerGrid Infrastructure Investment Trust on Wednesday raised a little over Rs 3,480 crore from anchor investors ahead of its initial public offer, which opens for subscription on Thursday
The Tamilnad Mercantile Bank will turn 100 this year
India had 22 IPOs worth $2.6 bn in Q1 of Calendar 2021 versus 12 IPOs at the same time last year, was ranked ninth globally on number of offerings for the quarter
The trend is likely to stay bullish in the current quarter also, according to a report.
Through the maiden offering Canadian firm Sun Life Financial will divest its 12.56% holding, while Aditya Birla Capital will sell a little less than 1%
The board of Aditya Birla Capital on April 14 had approved the IPO of Aditya Birla Sun Life AMC
Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed paperwork to go public
The board has approved an offer for sale of up to 2.8 million shares at face value of Rs 5 held by the company in the AMC, the firm said in a notification to exchanges, according to reports